160 related articles for article (PubMed ID: 34509154)
1. Clinicopathologic features and BRAF mutation status of tracheal glomus tumors - Characterization of 4 cases and the distinction from low-grade neuroendocrine tumors.
Lin J; Luo J; Chen H; Li Z; Shi Y; Sun H; Zhang Z; Zhou G; Zhong D
Ann Diagn Pathol; 2021 Dec; 55():151797. PubMed ID: 34509154
[TBL] [Abstract][Full Text] [Related]
2. BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics.
Karamzadeh Dashti N; Bahrami A; Lee SJ; Jenkins SM; Rodriguez FJ; Folpe AL; Boland JM
Am J Surg Pathol; 2017 Nov; 41(11):1532-1541. PubMed ID: 28834810
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological characterization of primary pulmonary and tracheal glomus tumors].
Zhao SN; Jin Y; Xie HK; Wu CY; Li Y; Zhang LP
Zhonghua Bing Li Xue Za Zhi; 2020 Dec; 49(12):1282-1287. PubMed ID: 33287514
[No Abstract] [Full Text] [Related]
4. Features of gastric glomus tumor: a clinicopathologic, immunohistochemical and molecular retrospective study.
Wang ZB; Yuan J; Shi HY
Int J Clin Exp Pathol; 2014; 7(4):1438-48. PubMed ID: 24817939
[TBL] [Abstract][Full Text] [Related]
5. [Gastric glomus tumors expressing synaptophysin: clinicopathologic and immunohistochemical analyses].
Wang JC; Jin XF; Weng SX; Xu C; Gan MF
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):756-759. PubMed ID: 29136687
[No Abstract] [Full Text] [Related]
6. Gastroesophageal Glomus Tumors: Clinicopathologic and Molecular Genetic Analysis of 26 Cases With a Proposal for Malignancy Criteria.
Papke DJ; Sholl LM; Doyle LA; Fletcher CDM; Hornick JL
Am J Surg Pathol; 2022 Oct; 46(10):1436-1446. PubMed ID: 35703141
[TBL] [Abstract][Full Text] [Related]
7. Synaptophysin Positive Glomus Tumor of Trachea Simulating Typical Carcinoid: A Potential trap.
Kamboj M; Durga G; Pasricha S; Darlong LM; Jajodia A; Gupta G; Sharma A; Koyyala VPB; Mehta A
Head Neck Pathol; 2021 Sep; 15(3):994-998. PubMed ID: 33025460
[TBL] [Abstract][Full Text] [Related]
8. Intraneural glomus tumor of "uncertain malignant potential" and with BRAF mutation in the median nerve - an unusual case.
Dahlin LB; Scherman P; Besjakov J; Lindberg E; Solomon DA; Horvai AE; Perry A
Clin Neuropathol; 2017; 36(4):164-170. PubMed ID: 28438258
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological features and diagnosis of pericytic tumors of the kidney].
He YL; Zou YW; Hu YJ; Wu J; Zhang W; Yu WJ; Li YJ; Jiang YX
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):987-992. PubMed ID: 36207911
[No Abstract] [Full Text] [Related]
10. Glomus tumor of the trachea: a rare case report.
Wang H; Xie J; Tan Y; Jiang J
Int J Clin Exp Pathol; 2015; 8(8):9723-6. PubMed ID: 26464745
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases.
Miettinen M; Paal E; Lasota J; Sobin LH
Am J Surg Pathol; 2002 Mar; 26(3):301-11. PubMed ID: 11859201
[TBL] [Abstract][Full Text] [Related]
12. BRAF and KRAS mutations in sporadic glomus tumors.
Chakrapani A; Warrick A; Nelson D; Beadling C; Corless CL
Am J Dermatopathol; 2012 Jul; 34(5):533-5. PubMed ID: 22317887
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic features of glomus tumor of the kidney].
Zhao M; Wang AX; Zhu X; Yu JJ; Wang W; Zhang DH; He XL; He HY; Teng XD
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):580-584. PubMed ID: 30107661
[No Abstract] [Full Text] [Related]
14. Clinicopathologic features and immunohistochemical spectrum of 11 cases of epithelioid malignant peripheral nerve sheath tumors, including INI1/SMARCB1 results and BRAF V600E analysis.
Rekhi B; Kosemehmetoglu K; Tezel GG; Dervisoglu S
APMIS; 2017 Aug; 125(8):679-689. PubMed ID: 28452074
[TBL] [Abstract][Full Text] [Related]
15. [Bronchial glomus tumor: report of 2 cases and review of the literature].
Zhang X; Zhu Y; Wang X; Miao J; Li H; Tong Z
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Oct; 37(10):758-63. PubMed ID: 25537412
[TBL] [Abstract][Full Text] [Related]
16. [Gastrointestinal glomus tumors: a clinicopathological analysis of fifteen cases].
Ma YH; Li P; Jiang GZ; Jin RJ; Li WC
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):22-27. PubMed ID: 31914530
[No Abstract] [Full Text] [Related]
17. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
18. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms.
Behling F; Barrantes-Freer A; Skardelly M; Nieser M; Christians A; Stockhammer F; Rohde V; Tatagiba M; Hartmann C; Stadelmann C; Schittenhelm J
Diagn Pathol; 2016 Jun; 11(1):55. PubMed ID: 27350555
[TBL] [Abstract][Full Text] [Related]
19. Intrathoracic glomus tumors and glomangiosarcomas: a clinicopathological and immunohistochemical study of 14 cases with emphasis on anatomic distribution.
Weissferdt A; Kalhor N; Moran CA
Virchows Arch; 2016 Nov; 469(5):541-546. PubMed ID: 27591766
[TBL] [Abstract][Full Text] [Related]
20. A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan.
Huang WK; Kuo TT; Wu CE; Cheng HY; Hsieh CH; Hsieh JJ; Shen YC; Hou MM; Hsu T; Chang JW
Asia Pac J Clin Oncol; 2016 Dec; 12(4):403-408. PubMed ID: 27488807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
